Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.
Jan 2011 - J. Clin. Oncol.; 29(3):1527-7755 [PMID:21149657]
[Okada H] [Kalinski P] [Ueda R] [Hoji A] [Kohanbash G] [Donegan TE] [Mintz AH] [Engh JA] [Bartlett DL] [Brown CK] [Zeh H] [Holtzman MP] [Reinhart TA] [Whiteside TL] [Butterfield LH] [Hamilton RL] [Potter DM] [Pollack IF] [Salazar AM] [Lieberman FS]

A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.
Mar 2009 - Cancer Ther; 6(B):1543-9143 [PMID:19129927]
[Lepisto AJ] [Moser AJ] [Zeh H] [Lee K] [Bartlett D] [McKolanis JR] [Geller BA] [Schmotzer A] [Potter DP] [Whiteside T] [Finn OJ] [Ramanathan RK]